Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,741 to 1,760 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression. | Front Oncol | 2021 | 33763348 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers amid CXC Chemokines in Ovarian Carcinoma Microenvironment. | J Oncol | 2021 | 33763130 | PubTator, text mining | PubMed |
| EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells. | BMC Cancer | 2021 | 33761896 | PubTator, text mining | PubMed |
| A single-cell survey of the human glomerulonephritis. | J Cell Mol Med | 2021 | 33754492 | PubTator, text mining | PubMed |
| MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer. | Theranostics | 2021 | 33754052 | PubTator, text mining | PubMed |
| Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer. | Front Genet | 2021 | 33747044 | PubTator, text mining | PubMed |
| Luteal Phase Ovarian Stimulation versus Follicular Phase Ovarian Stimulation results in different Human Cumulus cell genes expression: A pilot study. | Int J Med Sci | 2021 | 33746576 | PubTator, text mining | PubMed |
| COVID-19 and the human innate immune system. | Cell | 2021 | 33743212 | PubTator, text mining | PubMed |
| Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19. | Sci Rep | 2021 | 33742062 | PubTator, text mining | PubMed |
| IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin. | Transl Oncol | 2021 | 33735820 | PubTator, text mining | PubMed |
| Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma. | Front Cell Dev Biol | 2021 | 33732694 | PubTator, text mining | PubMed |
| Shenlian extract protects against ultrafine particulate matter-aggravated myocardial ischemic injury by inhibiting inflammation response via the activation of NLRP3 inflammasomes. | Environ Toxicol | 2021 | 33729688 | PubTator, text mining | PubMed |
| SARS-CoV-2 Infection of Airway Epithelial Cells. | Immune Netw | 2021 | 33728096 | PubTator, text mining | PubMed |
| Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19. | Front Immunol | 2021 | 33717168 | PubTator, text mining | PubMed |
| Common and Rare Variants Genetic Association Analysis of Circulating Neutrophil Extracellular Traps. | Front Immunol | 2021 | 33717105 | PubTator, text mining | PubMed |
| Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection? | Front Endocrinol (Lausanne) | 2021 | 33716989 | PubTator, text mining | PubMed |
| NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma. | Cancer Biol Med | 2021 | 33710809 | PubTator, text mining | PubMed |
| A dysfunctional TRPV4-GSK3β pathway prevents osteoarthritic chondrocytes from sensing changes in extracellular matrix viscoelasticity. | Nat Biomed Eng | 2021 | 33707778 | PubTator, text mining | PubMed |
| Pro- and Antitumorigenic Capacity of Immunoproteasomes in Shaping the Tumor Microenvironment. | Cancer Immunol Res | 2021 | 33707310 | PubTator, text mining | PubMed |
| Effect of concentration and duration of particulate matter exposure on the transcriptome and DNA methylome of bronchial epithelial cells. | Environ Epigenet | 2021 | 33692908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=88